Page 84 - Read Online
P. 84

Ackerman et al. Mini-invasive Surg 2021;5:14  https://dx.doi.org/10.20517/2574-1225.2021.02  Page 3 of 19

                                                 [18]
               while an RAI of ≥ 37 had a PPV of 10.7% .

               Disease specific
               In addition to the aforementioned assessments, additional testing is performed selectively based on the
               patient’s underlying ailment.

               Malignancy
               Once malignancy is confirmed by endoscopic biopsy, staging is completed with endoscopic ultrasound
               (EUS), computed tomography (CT) with fluorodeoxyglucose-18 positron emission tomography (PET),
                                                          [19]
               and/or staging laparoscopy with gastric extension . Upfront surgery is offered for selected patients with
               node-negative clinical T1a or T1b tumors, and patients with T2 N0 disease. For patients with potentially
               resectable disease that are clinically node-positive or at high-risk for node positivity (cT3-4), neoadjuvant
               chemotherapy with or without radiation is performed before restaging and consideration for surgery.
               Patients with local-regional disease unfit for surgery are treated with definitive chemoradiotherapy. This
               approach echoes with that outlined by the American Society of Clinical Oncology in their recent
                       [20]
               guideline .

               Benign
               Less commonly performed for benign indications than for malignant, esophagectomy remains a definitive
               treatment for several conditions. End-stage achalasia, previously failed (often multiple) operations for
               gastroesophageal  reflux  disease  (GERD)  and/or  hiatal  hernia,  and  trauma  account  for  84%  of
                                                  [21]
               esophagectomies for benign indications . Other less common indications in selected patients include
               motility orders (diffuse esophageal spasm, scleroderma), strictures, benign tumors, spontaneous or
               iatrogenic perforations, congenital anomalies, and caustic ingestion.


               The preoperative workup is tailored to the exact benign indication. At a minimum, esophagoscopy and
               fluoroscopic esophagram are required. Frequent additions include but are not limited to CT scans,
               esophageal manometry, esophageal pH monitoring, endoscopic ultrasound, endobronchial ultrasound,
               gastric emptying studies, and bronchoscopy.


               OPERATIVE TECHNIQUE
               Despite many technological advances, the principles and techniques of minimally invasive esophagectomy
               at the University of Pittsburgh remain largely unchanged from Dr. Luketich’s early description in the
               1990s [2,22-24] . Especially for those with prior minimally invasive esophageal surgery experience, the robotic
               techniques described are largely an evolution of the traditional minimally invasive concepts rather than a
               unique procedure, albeit with far more sophisticated instrumentation . Here, we describe in detail the Ivor
                                                                         [25]
               Lewis esophagectomy for malignant diseases and also discuss minor differences in procedures for benign
               indications.


               Pre-incision
               Although often overlooked, the period prior to an incision should be used as an opportunity to maximize
               the chances of a successful surgery. The team should review the case specifics ahead of time and outline a
               clear plan for the conduct of the operation. Attention should be paid to emergency contingencies and plans
               for such events should be verbalized.
   79   80   81   82   83   84   85   86   87   88   89